Breast Cancer Research Review Issue 78, 2025

In this edition:

  • Potential of WGS data linked to mortality statistics in breast cancer
  • Targeting dormant tumour cells to prevent recurrent breast cancer
  • Patritumab deruxtecan in hormone receptor+, HER2− advanced breast cancer
  • Weight loss intervention for women with stage II/III breast cancer
  • ILD with trastuzumab deruxtecan in real-world advanced breast cancer
  • Ki67 for predicting endocrine sensitivity in oestrogen receptor+, HER2– breast cancer
  • Xentuzumab-abemaciclib-endocrine therapy in advanced breast cancer
  • First-line zanidatamab-docetaxel in HER2-positive breast cancer
  • FES- vs. FDG-PET-CT in oestrogen receptor+ metastatic invasive lobular breast cancer
  • Acupuncture for hot flushes in breast cancer